Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Carbapenem-resistant Enterobacterales harboring mcr-9.1

PROVIDER: PRJNA693599 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR13501400_1.fastq.gz	Fastqsanger.gz
	SRR13501401_1.fastq.gz	Fastqsanger.gz
	SRR13501402_1.fastq.gz	Fastqsanger.gz
	SRR13501339_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 97

Similar Datasets

Escherichia coli

Project description:mcr-harboring Enterobacterales

| PRJNA1006687 | ENA

Molecular Epidemiology of Enterobacterales Resistant to Antibiotics of Last Resort in Pregnant Women in Labour at a Tertiary Hospital

Project description:This study aims to determine the epidemiology of Enterobacteriaceae resistant to antibiotics of last resort in pregnant women in labour at a tertiary hospital, Pretoria, South Africa. Rectal swabs shall be used to screen for colonisation with CRE and colistin-resistant Enterobacteriales in pregnant women during labour. Carbapenem and colistin-resistant Enterobacterales can cause the following infections: bacteraemia; nosocomial pneumonia; urinary tract infections, and intra-abdominal infections. Due to limited treatment options, infections caused by these multidrug-resistant organisms are associated with a mortality rate of 40-50%. Screening for colonisation of carbapenem-resistant Enterobacteriaceae (CRE) and colistin-resistant Enterobacteriaceae will help implement infection and prevention measures to limit the spread of these multidrug-resistant organisms.

2022-07-20 | GSE208573 | GEO

Project description:Carbapenem-resistant Enterobacterales with blaKPC-harboring IncN plasmids

| PRJNA759273 | ENA

RNAseq transcriptome analysis of K. pneumoniae MS6671 with PBT2 and colistin

Project description:The emergence of polymyxin resistance in carbapenem-resistant and extended-spectrum -lactamase (ESBL)-producing bacteria is a critical threat to human health, and new treatment strategies are urgently required. Here, we investigated the ability of the safe-for-human use ionophore PBT2 to restore antibiotic sensitivity in polymyxin-resistant, ESBL-producing, carbapenem-resistant Gram-negative human pathogens. PBT2 was observed to resensitize Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii and Pseudomonas aeruginosa to last-resort polymyxin class antibiotics, including the less-toxic next-generation polymyxin derivative, FADDI-287. We were unable to select for mutants resistant to PBT2 + FADDI-287 in polymyxin resistant E. coli containing a plasmid-borne mcr-1 gene or K. pneumoniae carrying a chromosomal mgrB mutation. Using a highly invasive K. pneumoniae strain engineered for polymyxin resistance through mgrB mutation, we successfully demonstrated the efficacy of PBT2 + FADDI-287 in vivo for the treatment of Gram-negative sepsis. These data present a new treatment modality to break antibiotic resistance in high priority polymyxin-resistant Gram-negative pathogens.

2020-07-01 | GSE153553 | GEO

Project description:Lebanese carbapenem resistant Enterobacterales

| PRJNA892008 | ENA

Project description:Lebanese carbapenem resistant Enterobacterales

| PRJNA892032 | ENA

Escherichia coli strain:EC2800

Project description:Sequencing of carbapenem resistant Enterobacterales

| PRJNA644258 | ENA

Project description:Carbapenem-Resistant Enterobacterales from bloodstream

| PRJNA1088820 | ENA

Bacteria

Project description:Sequencing of carbapenem resistant Enterobacterales